Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2011 1
2012 2
2014 3
2015 2
2016 2
2017 6
2018 9
2019 5
2020 6
2021 9
2022 6
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Neuroimaging alterations and relapse in early-stage psychosis.
Mihaljevic M, Nagpal A, Etyemez S, Narita Z, Ross A, Schaub R, Cascella NG, Coughlin JM, Nestadt G, Nucifora FC, Sedlak TW, Calhoun VD, Faria AV, Yang K, Sawa A. Mihaljevic M, et al. Among authors: coughlin jm. J Psychiatry Neurosci. 2024 Apr 3;49(2):E135-E142. doi: 10.1503/jpn.230115. Print 2024 Jan-Feb. J Psychiatry Neurosci. 2024. PMID: 38569725 Free PMC article.
Imaging Brain Injury in Former National Football League Players.
Rubin LH, Du Y, Sweeney SE, O'Toole R, Thomas CL, Zandi AG, Shinehouse LK, Brosnan MK, Nam H, Burke ME, Bureau SC, Kilgore JJ, Yoon M, Soule AR, Lesniak WG, Minn I, Rowe SP, Holt DP, Hall AW, Mathews WB, Smith GS, Nowinski CJ, Kassiou M, Dannals RF, Pomper MG, Coughlin JM. Rubin LH, et al. Among authors: coughlin jm. JAMA Netw Open. 2023 Oct 2;6(10):e2340580. doi: 10.1001/jamanetworkopen.2023.40580. JAMA Netw Open. 2023. PMID: 37902750 Free PMC article.
[18F]FNDP PET neuroimaging test-retest repeatability and whole-body dosimetry in humans.
Du Y, Coughlin JM, Amindarolzarbi A, Sweeney SE, Harrington CK, Brosnan MK, Zandi A, Shinehouse LK, Sanchez ANR, Abdallah R, Holt DP, Fan H, Lesniak WG, Nandi A, Rowe SP, Solnes LB, Dannals RF, Horti AG, Lodge MA, Pomper MG. Du Y, et al. Among authors: coughlin jm. Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3659-3665. doi: 10.1007/s00259-023-06331-z. Epub 2023 Jul 17. Eur J Nucl Med Mol Imaging. 2023. PMID: 37458759
Exploring [11C]CPPC as a CSF1R-targeted PET Imaging Marker for Early Parkinson's Disease Severity.
Mills KA, Du Y, Coughlin JM, Foss CA, Horti AG, Jenkins K, Skorobogatova Y, Spiro E, Motley CS, Dannals RF, Song JJ, Choi YR, Redding-Ochoa J, Troncoso J, Dawson VL, Kam TI, Pomper MG, Dawson TM. Mills KA, et al. Among authors: coughlin jm. medRxiv [Preprint]. 2024 Feb 13:2023.05.28.23290647. doi: 10.1101/2023.05.28.23290647. medRxiv. 2024. PMID: 37398476 Free PMC article. Preprint.
Pilot imaging of the colony stimulating factor 1 receptor in the brains of virally-suppressed individuals with HIV.
Rubin LH, Du Y, Sweeney SE, O'Toole R, Harrington CK, Jenkins K, Lesniak WG, Veenhuis RT, Dastgheyb R, Severson J, Fan H, Holt DP, Hall AW, Dannals RF, Horti AG, Pomper MG, Coughlin JM. Rubin LH, et al. Among authors: coughlin jm. AIDS. 2023 Jul 15;37(9):1419-1424. doi: 10.1097/QAD.0000000000003572. Epub 2023 Apr 5. AIDS. 2023. PMID: 37070549
First-in-human imaging using [11C]MDTC: a radiotracer targeting the cannabinoid receptor type 2.
Du Y, Coughlin JM, Brosnan MK, Chen A, Shinehouse LK, Abdallah R, Lodge MA, Mathews WB, Liu C, Wu Y, Minn I, Finley P, Hall AW, Lesniak WG, Dannals RF, Horti AG, Pomper MG. Du Y, et al. Among authors: coughlin jm. Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2386-2393. doi: 10.1007/s00259-023-06170-y. Epub 2023 Mar 6. Eur J Nucl Med Mol Imaging. 2023. PMID: 36877235
Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis.
Merritt K, McCutcheon RA, Aleman A, Ashley S, Beck K, Block W, Bloemen OJN, Borgan F, Boules C, Bustillo JR, Capizzano AA, Coughlin JM, David A, de la Fuente-Sandoval C, Demjaha A, Dempster K, Do KQ, Du F, Falkai P, Galińska-Skok B, Gallinat J, Gasparovic C, Ginestet CE, Goto N, Graff-Guerrero A, Ho BC, Howes O, Jauhar S, Jeon P, Kato T, Kaufmann CA, Kegeles LS, Keshavan MS, Kim SY, King B, Kunugi H, Lauriello J, León-Ortiz P, Liemburg E, Mcilwain ME, Modinos G, Mouchlianitis E, Nakamura J, Nenadic I, Öngür D, Ota M, Palaniyappan L, Pantelis C, Patel T, Plitman E, Posporelis S, Purdon SE, Reichenbach JR, Renshaw PF, Reyes-Madrigal F, Russell BR, Sawa A, Schaefer M, Shungu DC, Smesny S, Stanley JA, Stone J, Szulc A, Taylor R, Thakkar KN, Théberge J, Tibbo PG, van Amelsvoort T, Walecki J, Williamson PC, Wood SJ, Xin L, Yamasue H, McGuire P, Egerton A; 1H-MRS in Schizophrenia Investigators. Merritt K, et al. Among authors: coughlin jm. Mol Psychiatry. 2023 May;28(5):2039-2048. doi: 10.1038/s41380-023-01991-7. Epub 2023 Feb 17. Mol Psychiatry. 2023. PMID: 36806762 Free PMC article.
Longitudinal changes in brain metabolites in healthy controls and patients with first episode psychosis: a 7-Tesla MRS study.
Wang M, Barker PB, Cascella NG, Coughlin JM, Nestadt G, Nucifora FC Jr, Sedlak TW, Kelly A, Younes L, Geman D, Palaniyappan L, Sawa A, Yang K. Wang M, et al. Among authors: coughlin jm. Mol Psychiatry. 2023 May;28(5):2018-2029. doi: 10.1038/s41380-023-01969-5. Epub 2023 Feb 2. Mol Psychiatry. 2023. PMID: 36732587 Free PMC article.
49 results